Press release
PEGylated Protein Therapeutics Market Expected to Reach $17,813 Million by 2025
PEGylated protein therapeutics are used in multiple conditions such as cancer, hemophilia, rheumatoid arthritis, ankylosing spondylitis, Crohn's disease, and others.
Get Sample Report with Detail TOC @ https://www.alliedmarketresearch.com/request-sample/3726?utm_source=openpr&utm_medium=ss
According to a new report published by Allied Market Research, titled, " PEGylated Protein Therapeutics Market by Product Type, Application, and Sales Channel: Global Opportunity Analysis and Industry Forecast, 2018-2025, the market was valued at $10,388 million in 2017, and is projected to reach $17,813 million by 2025, growing at a CAGR of 6.9% from 2018 to 2025. North America is anticipated to be the highest revenue contributor throughout the forecast period.
Major Players:
• Amgen Inc.
• AstraZeneca PLC
• Biogen Inc.
• F. Hoffmann-La Roche Ltd. (Genentech Inc.)
• Horizon Pharma plc.
• Leadiant Biosciences S.p.A.
• Merck & Co.Inc. (Schering-Plough Corporation)
• Pfizer Inc.
• Shire plc (Baxalta)
• UCB S.A.
Make a Purchase Enquiry of Report @ https://www.alliedmarketresearch.com/purchase-enquiry/3726?utm_source=openpr&utm_medium=ss
The factors that drive the growth of the global PEGylated protein therapeutics market are an increase in prevalence of chronic diseases, advantages offered by PEGylation, and strong presence of pipeline drugs are. However, high cost related to drug development and launch of generics during the forecast period is expected to impede the market growth.
In addition, high market potential in the untapped emerging economies and increase in adoption of PEGylated protein therapeutics are expected to provide many opportunities during the forecast period.
Key Benefits for Stakeholders:
• This report entails a detailed quantitative analysis of the current market trends from 2017 to 2025 to identify the prevailing opportunities along with the strategic assessment of global PEGylated protein therapeutics market.
• Market size and estimations are based on a comprehensive analysis of the applications and developments in the industry.
• A qualitative analysis based on innovative products facilitates strategic business planning.
• The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the PEGylated protein therapeutics industry.
For More Detail Information Speak with Experts @ https://www.alliedmarketresearch.com/connect-to-analyst/3726?utm_source=openpr&utm_medium=ss
About Us:
Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release PEGylated Protein Therapeutics Market Expected to Reach $17,813 Million by 2025 here
News-ID: 1499268 • Views: …
More Releases from Allied Market Research
Music Event Market is poised to reach USD 775.7 billion, growing at a 10.2% CAGR …
The music event market size was valued at $250.80 billion in 2023, and is estimated to reach $775.7 billion by 2035, growing at a CAGR of 10.2% from 2024 to 2035.
Get Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/A08029
Music events are live or virtual gatherings where performers showcase their musical talent to audiences, serving as a pillar of the entertainment industry. These events have various formats,…
Action Figure Toys Market is likely to grow at a CAGR of 5.3% through 2031, reac …
The action figure toys market was valued at $9 billion in 2021, and is estimated to reach $15.3 billion by 2031, growing at a CAGR of 5.3% from 2022 to 2031.
Request The Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/17487
The reason for the popularity of action figure toys is that it is a highly competitive market. As a result, there are numerous companies that manufacture these toys, and each…
Low-Cost Airlines Market to Observe Highest Growth of USD 543.1 billion with Gro …
The global low cost airlines market was valued at $298.0 billion in 2023, and is projected to reach $543.1 billion by 2034, growing at a CAGR of 5.7% from 2024 to 2034
Request The Sample PDF of This Report: @ https://www.alliedmarketresearch.com/request-sample/4562
Low cost airlines, also known as budget or no-frills carriers, are airlines that offer low fares by minimizing traditional services and amenities. They typically use a single aircraft…
5G in Aviation Market Overview by Increasing Demands and Sales By 2021-2030
The global 5G in aviation market size was valued at $0.70 billion in 2020, and is projected to reach $4.68 billion by 2030, registering with a CAGR of 22.8% from 2021 to 2030.
The growth of the global 5G in aviation market is driven by growth in air passenger traffic across the globe, rise in inclination toward R&D activities for 5G network and related technology development, and changing aviation industry outlook.
Download…
More Releases for PEG
Biopharma PEG Delivers Innovative PEG Solutions for Enhanced Drug Efficacy
Watertown, MA - October 24, 2024 - Biopharma PEG is excited to announce its extensive offerings of polyethylene glycol (PEG) products, including monofunctional, homobifunctional, heterobifunctional, and multi-arm PEGs, tailored for PEGylation in biopharmaceutical applications. With over 40 PEGylated drugs approved globally, the role of PEGylation in drug development is more critical than ever.
PEGylation provides numerous advantages, such as improved solubility, enhanced stability, and increased circulation time in the bloodstream. By…
Biopharma PEG Expands Multi-Arm PEG Product Line
Biopharma PEG, a leader in PEG derivatives, is excited to announce the expansion of its high-purity Multi-Arm PEG linker product line, catering to the evolving needs of the medical and bioorganic fields. These advanced PEG linkers are available in various functional groups and molecular weights ranging from 1k to 40k, offering unmatched versatility and performance for research and development in cutting-edge medical applications.
"Biopharma PEG is committed to delivering high-purity multi-arm…
Biopharma PEG Supplies PEG Products Used For Infectious Disease Vaccines
As of January 1, 2023, global vaccine development includes a total of 966 vaccine candidates, of which 23% (220) are traditional inactivated or attenuated vaccines. Advances in molecular technology have facilitated the development of other platforms, such as recombinant protein vaccines, nucleic acid vaccines, and viral vector vaccines, which have further diversified global vaccine development.
Recombinant protein vaccines accounted for the largest proportion of all pipeline in development, 22% (215), due…
Biopharma PEG Supplies PEG Products For Click Chemistry Reactions
What is "click chemistry"? "Click Chemistry", this is a literary name given to this kind of reaction by the Nobel Prize winner K.Burry Sharless, when the cards are put together, "click" (click). Simply put, it is to add two structures to two molecules respectively, and these two structures can be specifically combined to synthesize the required chemical molecules. One of the most famous click-chemistry reactions is the Cu-catalyzed azide-alkyne cycloaddition…
Biopharma PEG Develops PEG Linkers for Antibody Drug Conjugates
Antibody-drug conjugate (ADC) is one of the fastest growing fields in tumor therapy, which consists of monoclonal antibody (Antibody), linker (Linker) and active drug (Payload). So far, there are only 15 drugs on the market in the world. However, with the development of some perfect antibody modification techniques, advanced site-specific coupling techniques and powerful small-molecule toxins, ADC drug research has mushroomed and a large number of ADC drugs are in…
Biopharma PEG Provides Multi-arm PEG Derivatives Crosslinked Into Hydrogels
Polyethylene (ethylene glycol) is a hydrophilic polymer that can have a very high water content when cross-linked into a network. Polyethylene glycol (PEG) is a suitable material for biological applications because it does not normally elicit an immune response. Since the 1970s, PEG has been used to modify therapeutic proteins and peptides in order to increase their solubility, reduce their toxicity, and prolong their cyclic half-lives. In the late 1970s,…
